Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · IEX Real-Time Price · USD
2.400
+0.065 (2.78%)
Apr 19, 2024, 4:00 PM EDT - Market closed
Adaptive Biotechnologies Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ADPT stock have an average target of 6.80, with a low estimate of 5.00 and a high estimate of 10. The average target predicts an increase of 183.33% from the current stock price of 2.40.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ADPT stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +108.33% | Apr 4, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $11 → $5 | Hold | Maintains | $11 → $5 | +108.33% | Feb 16, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $11 → $8 | Buy | Maintains | $11 → $8 | +233.33% | Feb 15, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $13 → $6 | Buy | Maintains | $13 → $6 | +150.00% | Nov 13, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $13 → $10 | Hold | Maintains | $13 → $10 | +316.67% | Oct 24, 2023 |
Financial Forecast
Revenue This Year
179.34M
from 170.28M
Increased by 5.32%
Revenue Next Year
225.36M
from 179.34M
Increased by 25.66%
EPS This Year
-1.32
from -1.56
EPS Next Year
-1.06
from -1.32
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 194.4M | 269.2M | 322.5M |
| Avg | 179.3M | 225.4M | 292.7M |
| Low | 166.6M | 191.6M | 265.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 14.1% | 50.1% | 43.1% |
| Avg | 5.3% | 25.7% | 29.9% |
| Low | -2.2% | 6.8% | 17.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.27 | -0.68 | -0.38 |
| Avg | -1.32 | -1.06 | -0.85 |
| Low | -1.34 | -1.26 | -1.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.